Skip to main content
. 2022 Apr 27;41:100987. doi: 10.1016/j.gore.2022.100987

Table 1.

Differential Nuclear Receptor Expression in Carcinomatous versus Sarcomatous Components of Gynecologic Carcinosarcomas.

GR H-score ER H-score PR H-score AR H-score
Overall (n = 18) Sarcomatous - mean
(range)
144.4
(0–300)
3.1
(0–50)
1.7
(0–20)
0
(0–0)
Carcinomatous - mean
(range)
38.9
(0–160)
63.1
(0–300)
47.2
(0–210)
2.8
(0–20)
Mean of differences
(range)
105.6
(-70–300)
−60
(-270–5)
−45.6
(-210–0)
−2.8
(-20–0)
95% Confidence Interval 47.3–163.8 −107.4 to −12.6 −74.7 to −16.5 −5.6 to 0.1
P-value 0.002 0.002 <0.0001 0.04
Ovarian (n = 10) Sarcomatous - mean
(range)
185
(10–300)
0.5
(0–50)
3
(0–20)
0
(0–0)
Carcinomatous - mean
(range)
68
(10–160)
96.5
(0–300)
63
(0–210)
4
(0–20)
Mean of differences
(range)
117
(-70–290)
−91.5
(-270–0)
−60
(-210–0)
−4
(-20–0)
95% Confidence Interval 29.5 to 204.5 −173.9 to −9.1 −111.9 to −8.1 −9.0 to 1.0
P-value 0.01 0.008 0.007 0.08
Uterine (n = 8) Sarcomatous - mean
(range)
93.8
(0–300)
0.6
(0–5)
0
(0–0)
0
(0–0)
Carcinomatous - mean
(range)
2.5
(0–20)
21.3
(0–120)
27.5
(0–90)
1.3
(0–10)
Mean of differences
(range)
91.3
(0–300)
−20.6
(-40–5)
−27.5
(-90–0)
−1.3
(-10–0)
95% Confidence Interval −6.5 to 189 −56.2 to 15.0 −52.3 to −2.7 −4.2 to 1.7
P-value 0.005 0.11 0.005 0.38

Legend:

GR = glucocorticoid receptor; ER = estrogen receptor; PR = progesterone receptor; AR = androgen receptor.

p-value: computed using t-tests.

H-score was calculated by multiplying staining intensity (0 to 3 + ) by percentage of cells (0 to 100%) with staining.